Therapeutic receptor targets of ischemic preconditioning.
about
Calcium signaling as a mediator of cell energy demand and a trigger to cell deathThe Influence of Diabetes Mellitus in Myocardial Ischemic PreconditioningDipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibitionDelta opioid receptors: the link between exercise and cardioprotection.Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease.Protective ischaemia in patients: preconditioning and postconditioning.Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopyA kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart.Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept.Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning.Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator.The effect of an adenosine and lidocaine intravenous infusion on myocardial high-energy phosphates and pH during regional ischemia in the rat model in vivo.Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).
P2860
Q26786470-0666C090-5680-4E45-90C1-3D79D3564763Q28080349-587D85EE-5F57-4C31-85C2-54455A4230BAQ33522876-7874454F-AA89-4A6F-9153-D48087197AF5Q33917016-F4A19B18-83AD-4E14-8E22-B6F453BDF6DEQ34557326-105E73F9-304D-4FBD-A2DB-3E29892005A8Q35672947-D8A08676-4C31-4691-A12E-F7F726E16DDEQ36868364-728B5062-B101-4302-B3CA-5E31459CF975Q37240955-248DD5A3-A995-4DDA-B0E4-1699597B2218Q37346693-96AE711F-57C4-498F-A8BB-19CBD9EA1EDCQ42066771-76A991FE-A6D7-4BE3-AF47-27D14EB624C9Q44341032-AF7A9E22-6F25-4B64-A707-FA6C0DCA8035Q44796686-10BD1FEA-4E8C-459D-853C-4910AEE9D264Q45953509-2D0B2ACD-270E-406A-8A43-ABDF25A57F9CQ48643177-9E93C493-7699-4B0B-A229-93A4312135D5Q51545583-430D2AE1-1CE3-4D3D-8E2F-14390080AFFF
P2860
Therapeutic receptor targets of ischemic preconditioning.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Therapeutic receptor targets of ischemic preconditioning.
@ast
Therapeutic receptor targets of ischemic preconditioning.
@en
Therapeutic receptor targets of ischemic preconditioning.
@nl
type
label
Therapeutic receptor targets of ischemic preconditioning.
@ast
Therapeutic receptor targets of ischemic preconditioning.
@en
Therapeutic receptor targets of ischemic preconditioning.
@nl
prefLabel
Therapeutic receptor targets of ischemic preconditioning.
@ast
Therapeutic receptor targets of ischemic preconditioning.
@en
Therapeutic receptor targets of ischemic preconditioning.
@nl
P2093
P2860
P1476
Therapeutic receptor targets of ischemic preconditioning.
@en
P2093
Garrett J Gross
John A Auchampach
Ryan M Fryer
P2860
P304
P356
10.1016/S0008-6363(02)00316-4
P577
2002-08-01T00:00:00Z